Sectors: Media and Publicity Influencers, Entrepreneurs Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial intelligence technologies for drug discovery, biomarker development, and aging research. He also developed a range of deep multi-modal predictors of biological age using multiple data types. He recently made an impact with his proposals for clinical trials with low-dose rapamycin to protect elderly from COVID-19.